Shares of Smith & Nephew PLC (NYSE:SNN) saw strong trading volume on Friday . 764,494 shares changed hands during mid-day trading, an increase of 127% from the previous session’s volume of 337,450 shares.The stock last traded at $32.66 and had previously closed at $32.73.

Several equities research analysts have commented on the company. Zacks Investment Research downgraded Smith & Nephew PLC from a “hold” rating to a “sell” rating in a report on Wednesday, July 6th. Barclays PLC downgraded Smith & Nephew PLC from an “overweight” rating to an “equal weight” rating in a report on Wednesday, August 10th. Jefferies Group raised Smith & Nephew PLC from a “hold” rating to a “buy” rating in a report on Monday, May 9th. Finally, Beaufort Securities reissued a “hold” rating on shares of Smith & Nephew PLC in a report on Wednesday, August 10th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $37.00.

The company’s 50 day moving average price is $33.88 and its 200-day moving average price is $33.50. The stock has a market capitalization of $14.74 billion and a P/E ratio of 41.54.

A hedge fund recently raised its stake in Smith & Nephew PLC stock. Wells Fargo & Company MN boosted its stake in Smith & Nephew PLC (NYSE:SNN) by 4.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 380,789 shares of the company’s stock after buying an additional 15,869 shares during the period. Wells Fargo & Company MN owned 0.09% of Smith & Nephew PLC worth $13,556,000 as of its most recent filing with the SEC.

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.